| Dr Sharon Kay Goodwin Fogleman, MD | |
|
53 Queendale Ctr, Red Bird Clinic, Beverly, KY 40913-9608 | |
| (606) 598-5135 | |
| (606) 598-8942 |
| Full Name | Dr Sharon Kay Goodwin Fogleman |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 53 Queendale Ctr, Beverly, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609862952 | NPI | - | NPPES |
| 64056377 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 33565 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharon Kay Goodwin Fogleman, MD 53 Queendale Ctr, Red Bird Clinic, Beverly, KY 40913-9608 Ph: (606) 598-5135 | Dr Sharon Kay Goodwin Fogleman, MD 53 Queendale Ctr, Red Bird Clinic, Beverly, KY 40913-9608 Ph: (606) 598-5135 |
News Archive
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 349-361(13); DOI: https://doi.org/10.15212/CVIA.2017.0077 Keith C. Ferdinand, MD and Rohan Samson, MD from the Tulane University Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, USA consider nonobstructive coronary artery disease in women: risk factors and noninvasive diagnostic assessment.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed gastroenterologists estimate that (assuming no new data on adverse events emerge) they will treat fewer Crohn's disease patients with Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade by the end of 2010, while the percentage of biologics-treated patients receiving Abbott/Eisai's Humira will increase to 36 percent.
A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.
Virginia Commonwealth University Massey Cancer Center researchers recently conducted a study that found low-income and uninsured women in states that are not expanding their Affordable Care Act (ACA) Medicaid coverage are less likely to receive breast and cervical cancer screenings compared to states that are implementing expansions.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and CEO, and members of the NeurogesX management team, will host an Investor Day on Friday, April 30, 2010, from 8:15am-11:00am EDT in New York City
› Verified 7 days ago
Dr. Millard Lynn Fogleman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 53 Queendale Ctr, Red Bird Clinic, Beverly, KY 40913 Phone: 606-598-5135 Fax: 606-598-8942 |